| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35018-1mg | |||
| Carrier-Free | NBP2-35018-100ug | |||
| Carrier-Free | NBP2-35018-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34893-1mg | |||
| Carrier-Free | NBP2-34893-100ug | |||
| Carrier-Free | NBP2-34893-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52664-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50431-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23571-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23532-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12153-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12050-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-06663-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-22408-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12172-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-11988-0.025mg | |||
![SDS-Page: Human IL-13 Protein [NBP2-35018]](http://images.novusbio.com/fullsize/Human-IL-13-Protein-SDS-Page-NBP2-35018-img0001.jpg "SDS-Page: Human IL-13 Protein [NBP2-35018]")
![SDS-Page: Human GM-CSF Protein [NBP2-34893]](http://images.novusbio.com/fullsize/Human-GM-CSF-Protein-SDS-Page-NBP2-34893-img0001.jpg "SDS-Page: Human GM-CSF Protein [NBP2-34893]")
![Flow Cytometry: CD19 Antibody (4G7) - Chimeric [NBP2-52664] - Flow-cytometry using anti-CD19 antibody 4G7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of 4G7 (NBP2-52664, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD19-Antibody-4G7-Chimeric-Flow-Cytometry-NBP2-52664-img0001.jpg "Flow Cytometry: CD19 Antibody (4G7) - Chimeric [NBP2-52664] - Flow-cytometry using anti-CD19 antibody 4G7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of 4G7 (NBP2-52664, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: Complement Factor D/Adipsin Antibody (D10/4) - BSA Free [NBP2-23532] - Lane 1: Purified Factor D Lane 2: Factor D in human serum Lane 3: SDS-PAGE purified Factor D Lane 4: MW-marker](http://images.novusbio.com/fullsize/Complement-Factor-D-Adipsin-Antibody-D10-4-BSA-Free-Western-Blot-NBP2-23532-img0004.jpg "Western Blot: Complement Factor D/Adipsin Antibody (D10/4) - BSA Free [NBP2-23532] - Lane 1: Purified Factor D Lane 2: Factor D in human serum Lane 3: SDS-PAGE purified Factor D Lane 4: MW-marker")
![ELISA: Complement Factor D/Adipsin Antibody (D10/4) - BSA Free [NBP2-23532] - The calibration curve of a sandwich assay for Factor D using NBP2-23532 as the capture antibody and NBP2-23547 as the biotinylated detection antibody.](http://images.novusbio.com/fullsize/Complement-Factor-D-Adipsin-Antibody-D10-4-BSA-Free-ELISA-NBP2-23532-img0007.jpg)
![Western Blot: 2B4/CD244/SLAMF4 Antibody (MM0070-7D24) [NBP2-12153]](http://images.novusbio.com/fullsize/2B4-CD244-SLAMF4-Antibody-MM0070-7D24-Western-Blot-NBP2-12153-img0001.jpg "Western Blot: 2B4/CD244/SLAMF4 Antibody (MM0070-7D24) [NBP2-12153]")
![Immunohistochemistry-Paraffin: BCAM/CD239 Antibody (MM0107-1M39) [NBP2-12050] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/BCAM-CD239-Antibody-MM0107-1M39-Immunohistochemistry-Paraffin-NBP2-12050-img0001.jpg "Immunohistochemistry-Paraffin: BCAM/CD239 Antibody (MM0107-1M39) [NBP2-12050] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: IFN-gamma R1/CD119 Antibody (RM0093-7K23) [NBP1-22408] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP1-22408](http://images.novusbio.com/fullsize/IFN-gamma-R1-CD119-Antibody-RM0093-7K23-Immunohistochemistry-Paraffin-NBP1-22408-img0001.jpg "Immunohistochemistry-Paraffin: IFN-gamma R1/CD119 Antibody (RM0093-7K23) [NBP1-22408] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP1-22408")
![Western Blot: CD58/LFA-3 Antibody (MM0176-8G24) [NBP2-12172] - Lysates of human lung tissues](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-MM0176-8G24-Western-Blot-NBP2-12172-img0001.jpg "Western Blot: CD58/LFA-3 Antibody (MM0176-8G24) [NBP2-12172] - Lysates of human lung tissues")
![Immunohistochemistry-Paraffin: ULBP-3 Antibody (MM0594-6E12) [NBP2-11988] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/ULBP-3-Antibody-MM0594-6E12-Immunohistochemistry-Paraffin-NBP2-11988-img0001.jpg "Immunohistochemistry-Paraffin: ULBP-3 Antibody (MM0594-6E12) [NBP2-11988] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.")